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Purpose: To explore the heterogeneity of the literature on psychological interventions for 
psychological difficulties in people with Parkinson’s disease (PD).  
Methods: A scoping review was performed across five major databases (MEDLINE 
Complete, PsycINFO, CINAHL, Academic Search Ultimate, and Cochrane Library) up 
to June 2020.  
Results: From an initial return of 4911 citations, 56 studies were included, of which 21 
were RCTs. A relatively wide range of therapeutic models have been adopted with people 
with PD, from common therapies such as cognitive behavioural therapy (CBT) and 
mindfulness, to less frequent approaches, e.g., acceptance and commitment therapy 
(ACT) and psychodrama. The clinical implications of the findings are discussed, and 
suggestions are provided for future research on intervention studies and key 
psychological outcomes. 
Conclusions: CBT appears to be effective in treating depression and sleep disorders in 
people with PD, while psychoeducation programmes alone should be avoided. The use 
of CBT to improve anxiety, quality of life, and impulse control, as well mindfulness-
based interventions, should be undertaken with some caution because of insufficient 
research and inconsistent results. As we enter the new decade, more high-quality evidence 
is required for psychological interventions in people with PD in general, and to 
corroborate preliminary positive findings on the adoption of less frequent approaches 
such as ACT. 
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Parkinson’s disease (PD) is a progressive neurodegenerative condition caused by the 
death of dopaminergic neurons in the substantia nigra pars compacta of the basal ganglia. 
This leads to disorders of movement which include bradykinesia, muscular rigidity, rest 
tremor, and postural and gait impairment (Kalia & Lang, 2015). Other difficulties involve 
affect, sleep, pain, gastrointestinal and autonomic symptoms (Chaudhuri & Schapira, 
2006; Weintraub & Burn, 2011), as well as cognitive deterioration which may ultimately 
lead to dementia (Emre, 2007; McKeith & Burn, 2000). Motor symptoms usually appear 
after the age of 50, although younger onset is also possible (Willis, Schootman, Kung, & 
Racette, 2013). PD is the second most common neurodegenerative disease in older people 
(after Alzheimer’s disease), affecting around 1 in 500 individuals in the UK (Mark, 2006). 
Its worldwide prevalence ranges from 1 to 418 per 100,000 (Zhang & Roman, 1993) and, 
due to the ageing population, is expected to increase by 50% by 2030 (Dorsey et al., 
2007). There is no definitive diagnostic test for PD and diagnosis is usually made 
following the emergence of motor symptoms (Gelb, Oliver, & Gilman, 1999).  
Psychological difficulties in people with PD 
PD is most commonly conceived as a motor disorder and psychological problems are 
often under-recognised by healthcare professionals (Barbosa, 2013). In fact, people with 
PD can experience a wide range of psychological difficulties, including anxiety, 
depression, apathy, impulse control disorders, and more rarely psychosis (ffytche et al., 
2017; Simpson, McMillan, & Reeve, 2013). 
Anxiety is especially common in PD, affecting up to 55% of people with the 
condition (Yamanishi et al., 2013). It is often diagnosed as generalised anxiety disorder 
(GAD), followed closely by social phobia and non-specific clinically relevant anxiety. 
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Diagnoses of  panic disorder, obsessive compulsive disorder (OCD), and agoraphobia 
tend to be more rare (Broen, Narayen, Kuijf, Dissanayaka, & Leentjens, 2016). 
Similarly, the prevalence of depression in people with PD is estimated to be as high as 
56% (Yamanishi et al., 2013), with a diagnosis of minor depression being the most 
frequent, followed by major depressive disorder and dysthymia (Reijnders, Ehrt, Weber, 
Aarsland, & Leentjens, 2008). In addition, around 40% of individuals might hold 
concurrently diagnoses of anxiety and depression (Yamanishi et al., 2013).  
All psychological difficulties in PD may occur at any time throughout the course 
of the disease – sometimes preceding formal diagnosis by many years (Goldman & 
Postuma, 2014) – and can be as disabling as motor symptoms (Goldman & Holden, 
2014), with their severity representing a key predictor of health-related quality of life in 
affected individuals (Leroi et al., 2011). However, our understanding of the 
psychological impact of PD has been historically dominated by neurobiological 
conceptualisations (Brown & Jahanshahi, 1995). These assume that psychological 
difficulties largely occur as a result of pathophysiological processes, such as changes in 
dopaminergic systems (Chaudhuri & Schapira, 2009). Only more recently has it been 
recognised that psychological issues in PD are likely caused by a mixture of 
neurobiological, psychological, and indeed social factors, depending on the individual’s 
specific presentation (Simpson, Lekwuwa, & Crawford, 2013). As a result, more 
psychologically-informed interventions for people with PD have recently been 
developed and implemented, with a number of reviews reporting mixed results for 
cognitive behavioural therapy (CBT) and approaches focused on mindfulness, in 
particular for anxiety and depression (Armento et al., 2012; Berardelli et al., 2015; 
Ghielen et al., 2019; Xie et al., 2015; Zečević, 2020).  
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However, the vast majority of reviews and meta-analyses on this topic selectively 
focus on specific therapies with the aim of examining their effectiveness, with most 
failing to encompass the heterogeneity of models and approaches. In fact, only one recent 
umbrella review has endeavoured to shed light on the variety of psychological 
interventions for PD (Kampling, Brendel, & Mittag, 2019). The results confirmed the 
heterogenous evidence for CBT’s effectiveness and reported novel insight into less 
investigated approaches (e.g., psychodrama), but failed to identify any of the existing 
studies which explored mindfulness-based therapies. Moreover, the search strategy 
showed a strong focus on cognitive interventions and was significantly limited in scope 
over time, only including publications between 2000 and 2018.   
 As we have recently passed the second centenary of PD’s first description 
(Parkinson, 1817) and have now entered the 2020s, our current understanding of the 
applications of various psychological interventions in this population appears very 
limited. Consequently, the overarching aim of the present review was to provide a 
comprehensive account of the heterogeneity and effectiveness of approaches to 
psychological interventions adopted to date with individuals affected by Parkinson’s.  
Methods 
Identifying the research question 
The present addressed the following research question: which psychological 
interventions have been explored so far with PD, and what is their effectiveness? To 
answer this, a scoping review was performed, in accordance with the latest guidelines 
from The Joanna Briggs Institute (Peters et al., 2020). This approach was adopted in 
order to explore methodologically heterogenous topics (i.e., both quantitative and 
qualitative) with a systematic and replicable search strategy without the need for narrow 
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research questions, as in traditional systematic reviews (Arksey & O’Malley, 2005).  
Identifying relevant studies 
To be included in the present review, studies had to: a) be related to people with PD; b) 
involve individuals aged 18 or above; and c) describe the delivery of any psychological 
intervention targeting psychological outcomes in PD. Qualitative studies were included 
if consisting of evaluations of psychological interventions.  
Studies not related to the concept under investigation, not published in full in the 
English language, enrolling individuals aged 17 or under, not providing sufficient details 
on the adopted intervention (e.g., methodological approach), or involving mainly animal 
models were excluded. Systematic reviews, reviews, commentaries, editorials, 
conference proceedings, and letters were also excluded. As the overarching aim of this 
study was to investigate psychological interventions for psychological difficulties in 
people with PD specifically, interventions targeting physical symptoms or aimed only at 
family members and/or carers, as well as studies focusing only on cognition and/or 
neuroimaging were not included. 
Study selection 
A comprehensive search was carried out across five major databases (Academic Search 
Ultimate, CINAHL, Cochrane Library, PsycINFO, PubMed) up until June 1st 2020, using 
a combination of free text terms. Reference lists of included citations and key reviews 
were also hand-searched to identify any further relevant studies. The logic grid for the 
search strategy is illustrated in Table 1, while Table 2 provides details on the terms 
adopted in the searches. 
As current guidelines on scoping reviews do not consider a formal quality 
assessment appropriate for this methodology (Peters et al., 2020), this was not carried 
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out for the present review. Nevertheless, efforts were made when possible to highlight 
any methodological and clinical limitations in the included citations, as well as which 
studies adopted more robust methodologies such as randomised control trials (RCTs).  
Charting the data 
First, the raw results from the searches were filtered for duplicate citations and studies 
not fully in English. Following this, all titles and abstracts were screened by one reviewer 
(NZ) against the abovementioned inclusion criteria. In a second phase, all remaining full-
text articles were screened for eligibility by three reviewers (NZ, FE, JF) and confirmed 
by two more (IL, JS). Although rare, any disagreements between reviewers around the 
inclusion of studies were solved with collective discussions involving all the authors. The 
PRISMA flow diagram for the study selection is illustrated in Figure 1.  
Collating, summarising, and reporting the results 
Data were extracted independently by three reviewers (NZ, IL, AP) and double-checked 
for accuracy by a further two (FE, JS).  
Consultation 
Since the present study was part of a larger project aimed at drawing the first UK 
national guidance on psychological approaches to people with neurodegenerative 
diseases ([name]), a number of stakeholders including key academics and third sector 
organisations were consulted to review the research question and methodology. 
Results 
The database searches identified a total of 4911 citations, reduced to 2094 following the 
initial filtering for duplicates and language. From these, the screening of titles and 
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abstracts led to the exclusion of 2006 studies, leaving 88 full-text articles to consider. A 
total of 56 studies were eventually included, whose key characteristics and results are 
showed in Table 3. The findings of the included studies are reported below, categorised 
by therapeutic approach.    
Cognitive Behavioural Therapy (CBT) 
CBT holds that emotional distress and behavioural difficulties arise from “maladaptive” 
or unhelpful cognitions, which comprise general beliefs about the world, the self, and the 
future (Hofmann, Asnaani, Vonk, Sawyer, & Fang, 2012). The therapy is predicated on 
the assumption that changing these cognitions through therapeutic interventions will 
reduce distress and problematic behaviours. A total of 36 studies have been carried out to 
evaluate interventions based on CBT for psychological difficulties in PD, of which only 
around a third (i.e., 11) were RCTs. The main psychological outcomes addressed were 
anxiety, depression, quality of life, sleep disorders, and impulse control disorders. While 
some studies addressed multiple outcomes with their intervention, for the sake of clarity 
the results are presented separately for each outcome. 
Anxiety 
The results from experimental studies targeting anxiety appear to be mixed. Two RCTs 
with small sample sizes (Calleo et al., 2015; Wuthrich & Rapee, 2019) both administered 
CBT individually either in person or via telephone, and found no significant 
improvements in anxiety when compared to waitlist controls or enhanced care. Another 
similarly sized RCT (Troeung, Egan, & Gasson, 2014) compared group CBT to waitlist 
controls, and found significant and large improvement effects for anxiety at post-
intervention, as well as at 1-month and 6-month follow-ups. A slightly larger RCT 
adopting telephone-based CBT tailored for depression also reported significant 
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improvements in anxiety (Dobkin et al., 2020). Similar findings were obtained by two 
quasi-experiments, which found a significant positive effect for the CBT group post-
intervention when compared to psychoeducation (Berardelli et al., 2018) or no treatment 
(Dreisig, Beckmann, Wermuth, Skovlund, & Bech, 1999). However, mixed results were 
observed in an RCT comparing a CBT-based self-help guided reading resource to 
provision of simple information about worry (Lawson, Millar, Brown, & Burn, 2013), 
finding initial significant reductions for the primary outcome of worry for the intervention 
group, but no differences in final outcomes at the end of the three months of treatment. 
In addition, another RCT comparing internet-based CBT with treatment as usual (TAU) 
reported significant differences for anxiety between the intervention group and controls, 
but also observed how this was not accompanied by significant improvements in the 
intervention within-group analysis, suggesting that the effect could be at least partly 
explained by deterioration in the control group. 
On the other hand, the observational studies adopting CBT as the primary 
intervention for anxiety have reported mostly positive findings. Group CBT for 12 weeks 
was found to lead to significant improvements in anxiety post-intervention in an 
uncontrolled pretest-posttest design (Berardelli et al., 2015), and a similar study also 
found that improvements were maintained at three and six months (Dissanayaka et al., 
2017). This was consistent with the findings from a number of case studies (Macht, 
Pasqualini, & Taba, 2007; Mohlman et al., 2010; Richardson & Marshall, 2012; Veazey, 
Cook, Stanley, Lai, & Kunik, 2009) except for one (Feeney, Egan, & Gasson, 2005), 
which did not observe any significant improvements for anxiety. Similar positive findings 
were also reported by two studies adopting a multiple baseline single-subject 
experimental design (SSED; Lebrun, Gély-Nargeot, Rossignol, Geny, & Bayard, 2019; 
Reynolds, Saint-Hilaire, Thomas, Barlow, & Cronin-Golomb, 2019), which found 
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significant reductions in anxiety at post-treatment maintained at 6-week and 3-month 
follow-up. 
Depression 
The current evidence from experimental studies suggests that CBT is superior to TAU for 
improving low mood in PD, either when delivered individually (Dobkin, Menza, Allen, 
Gara, et al., 2011; Wuthrich & Rapee, 2019) or in a group (Troeung et al., 2014), as well 
as over the phone (Dobkin et al., 2020) and the internet (Kraepelien et al., 2020). Most of 
these studies enrolled participants who met clinical criteria for depression at baseline 
using validated scales, and those which reported effect sizes described at least medium-
sized effects (Dobkin, Menza, Allen, Gara, et al., 2011; Wuthrich & Rapee, 2019). Two 
other small RCTs found CBT to be superior to psychoeducation and/or monitoring, either 
at post-treatment (Veazey et al., 2009), or at 1-month follow-up (Calleo et al., 2015). 
However, these were both limited by small participant numbers and relatively high 
attrition rates. Positive results for depression were also observed by two quasi-
experiments comparing CBT against psychoeducation (Berardelli et al., 2018) and no 
treatment (Tiihonen, Lankinen, & Viemerö, 2012), as well as two multiple baseline 
SSEDs adopting CBT for insomnia (Lebrun et al., 2019; Reynolds et al., 2019). One of 
the quasi-experiments also reported significant improvements in apathy (Berardelli et al., 
2018). 
A number of observational studies have reported CBT to be useful for improving 
low mood in  PD. These included uncontrolled pretest-posttest designs (Berardelli et al., 
2015; Dobkin, 2014; Dobkin, Allen, & Menza, 2007; Dobkin, Interian, Durland, Gara, & 
Menza, 2018; Dobkin, Menza, Allen, Tiu, et al., 2011; Shinmei et al., 2016), case series 
(Cole & Vaughan, 2005; Dobkin, Allen, & Menza, 2006; Feeney et al., 2005), and a single 
case study (Richardson & Marshall, 2012). Some of the improvements in mood were also 
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maintained at 1-month (Dobkin et al., 2006; Feeney et al., 2005) and 3-month (Shinmei 
et al., 2016) follow-ups.  
Quality of life 
The current evidence on the effectiveness of CBT to improve quality of life in PD is 
characterised by contrasting results, for both experimental and observational studies. 
Positive findings were reported by experimental designs which compared CBT to a health 
enhancement programme (Hadinia et al., 2016) and no treatment (Tiihonen et al., 2012). 
Similar positive effects were reported when adopting internet-based CBT (Kraepelien et 
al., 2020), while the use of telephone-based CBT yielded positive results in one RCT 
(Dobkin et al., 2020), but not in another (Wuthrich & Rapee, 2019).  
Findings from observational studies showed significant improvements in quality 
of life post-intervention after group CBT (Berardelli et al., 2015) or brief CBT (Osawa, 
Kamei, Nozaki, Furusawa, & Murata, 2020), but no notable differences at all time points 
after mixed in-person and telephone-delivered individual CBT in another (Veazey et al., 
2009).  
Sleep disorders 
To date, CBT has shown very promising results for treating sleep disorders in PD. In 
particular, four RCTs showed significant improvements in participants’ levels of 
insomnia and sleep quality when comparing face-to-face or computerised CBT with 
education on basic sleep hygiene (Leroi, Baker, Kehoe, Daniel, & Byrne, 2010; Patel et 
al., 2017), sham light therapy (Rios Romenets et al., 2013), or TAU (Kraepelien et al., 
2020). Similarly, positive findings were observed in a multiple baseline SSED (Reynolds 
et al., 2019), an uncontrolled pretest-posttest design (Yang & Petrini, 2012), and two case 
series (Humbert, Findley, Hernandez-Con, & Chahine, 2017; Osawa et al., 2020), with 
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benefits being maintained at 3-month follow-up in some cases (Reynolds et al., 2019; 
Yang & Petrini, 2012).  
Impulse control disorders (ICDs) 
The extant evidence on the efficacy of CBT for impulse control disorders (ICDs) in PD 
is characterised by just two studies, showing mixed results. The larger investigation 
consists of an RCT which randomised 45 people with PD with ICDs to either an 
intervention involving 12 sessions of face-to-face CBT or a waitlist (Okai et al., 2013). 
At the 6-month outcome point, 44% of participants in the CBT group no longer met 
clinical criteria for an ICD, compared to 29% of waitlist controls.  
A second study (Jiménez-Murcia et al., 2012) adopted a quasi-experimental 
design to compare people with PD experiencing pathological gambling to controls with 
pathological gambling alone on 16 weekly sessions of CBT. The results revealed no 
difference between groups following the intervention. However, higher dropout and 
relapse rates were observed among the PD participants compared to those without PD.  
Mindfulness 
Mindfulness-based approaches focus on bringing the attention to the present moment and 
accepting feelings, sensations, and emotions non-judgementally, including the experience 
of illness (Kabat-Zinn, 2006). When adapted for neurological conditions, such 
approaches may emphasise acceptance of discomfort and physical changes, focusing on 
appreciation of the abilities and resources which remain, and may include elements of 
cognitive therapy (mindfulness-based cognitive therapy; MBCT) or focus on stress 
reduction (mindfulness-based stress reduction; MBSR).  
A total of 10 intervention studies have adopted approaches based on mindfulness 
to target psychological difficulties in PD. Of these, five  were RCTs (Advocat et al., 2016; 
 
13 
Kwok et al., 2019; Pickut et al., 2015; Rodgers et al., 2019; Son & Choi, 2018). The most 
commonly addressed psychological outcomes were anxiety, depression, and quality of 
life. As with CBT, while some interventions addressed more than one outcome, the results 
are presented separately for clarity.    
Anxiety 
The use of mindfulness-based interventions to address anxiety in PD has been evaluated 
by three RCTs (Kwok et al., 2019; Rodgers et al., 2019; Son & Choi, 2018) and two 
uncontrolled pretest-posttest studies (Birtwell et al., 2017; Dissanayaka et al., 2016). 
Most reported an improvement in anxiety post-intervention, with some effects maintained 
at 2-month (Birtwell et al., 2017) and 6-month follow-ups (Dissanayaka et al., 2016). 
However, one of the RCTs (Rodgers et al., 2019) did not find any significant 
improvements compared to waitlist controls. Moreover, there was some variation in terms 
of intervention delivery and content, with two studies using the same protocol based on 
six two-hour sessions of MBCT (Dissanayaka et al., 2016; Rodgers et al., 2019), two 
adopting an MBSR course (Birtwell et al., 2017; Son & Choi, 2018), and one an adapted 
yoga intervention that included components of mindfulness across eight 90-minute 
sessions (Kwok et al., 2019). A number of adaptations were made to account for the PD 
population, including omitting certain exercises involving motor or sensory components, 
shortening sessions and meditation practices, simplifying language, and using more 
relevant metaphors.  
Depression 
The current evidence on using mindfulness techniques to improve depression in PD 
consists of four RCTs (Kwok et al., 2019; Pickut et al., 2015; Rodgers et al., 2019; Son 
& Choi, 2018) and three uncontrolled pretest-posttest studies (Birtwell et al., 2017; Cash 
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et al., 2015; Dissanayaka et al., 2016), and shows mixed results. In particular, studies 
using MBCT or MBSR have reported significant improvements in depression (Cash et 
al., 2015; Rodgers et al., 2019), with large effect sizes. These findings are consistent with 
those from a qualitative investigation, which reported that people with PD who 
participated in a 8-week MCBT course found MCBT to be an acceptable and helpful form 
of group intervention (Fitzpatrick, Simpson, & Smith, 2010). Significant improvements 
were also observed following the adoption of mindfulness-based yoga, which were 
maintained at 3-month follow-up (Kwok et al., 2019). However, it should be noted that, 
unlike the CBT interventions, two of these studies excluded people with PD with major 
depression (Cash et al., 2015; Kwok et al., 2019), while one (Rodgers et al., 2019) used 
no depression inclusion criteria and found that the group average depression score was in 
the normal range. In addition, three other studies which adopted a form of MBSR found 
contrasting results, with one reporting significant improvements both post-intervention 
and at follow-up (Birtwell et al., 2017), one only reporting improvements at post-
intervention (Dissanayaka et al., 2016), and one reporting no effect on depression at all 
(Pickut et al., 2015).  
Quality of life 
Similarly to depression, the current findings on the impact of mindfulness-based 
interventions on quality of life in PD appear to be mixed. Among the RCTs, only one 
(Son & Choi, 2018) showed significant improvements in quality of life compared to 
waitlist when adopting an MBSR exercise programme, while the other two found no 
positive effect for an 8-week mindfulness-based intervention (Pickut et al., 2015) or a 
group mindfulness-based lifestyle programme (Advocat et al., 2016). However, a 
qualitative evaluation of the latter found that, following the intervention, many 
participants felt increased levels of perceived control and acceptance of disease 
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progression, as well as improved social relationships and self-confidence (Vandenberg et 
al., 2018).  
Considering the observational evidence, one uncontrolled pretest-posttest design 
found no significant effect on quality of life for an 8-week group MBSR course (Birtwell 
et al., 2017), while another reported significant improvements for a manualised group 
mindfulness intervention tailored for PD at post-intervention, but not at 6-month follow-
up (Dissanayaka et al., 2016).  
Psychoeducation 
Psychoeducation focuses on developing individuals’ understanding about illness and 
themselves in relation to their condition by providing of information and using exercises 
(Walsh, 2010). The aim is to empower the individual to manage their condition and their 
own reactions to it more successfully, and consequently improve their well-being. A total 
of four studies have so far examined the use of PD-specific psychoeducation programmes 
to manage daily aspects of the disease (e.g., diet and movement) and improve low mood, 
two of which were RCTs (Flores Alves Dos Santos et al., 2017; Guo et al., 2009).  
One RCT (Flores Alves Dos Santos et al., 2017) compared a group 
psychoeducation programme designed for people with PD undergoing subthalamic 
nucleus deep brain stimulation (STN-DBS) against standard STN-DBS aftercare. The 
results showed no significant difference in social adjustment between the two groups at 
1-year follow-up, although the finding became significant at 2-year. Another RCT (Guo 
et al., 2009) found that three 1-hour psychoeducation lectures and 24 subsequent 30-
minute individual sessions did not lead to an objective improvement in low mood when 
compared to waitlist controls. However, the study did not recruit people with PD who had 
clinically significant levels of depression, and the intervention group’s average 
depression score was in the normal range, making reductions harder to evidence. 
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An uncontrolled pretest-posttest design (Macht et al., 2007) evaluated a patient 
education programme based on information and self-monitoring sessions across seven 
European countries (Spain, Finland, Italy, The Netherlands, United Kingdom, Estonia, 
Germany). The results showed no significant improvements in self-rated depression or 
quality of life at post-intervention. A recent qualitative study (Soundy et al., 2019) 
explored the experiences of people with PD who underwent First Steps, a 2-day peer-led 
psychoeducational intervention for people with a new diagnosis of PD. The results 
showed that the participants engaged well with the programme, showing improved 
exercise behaviour and coping mechanisms at post-intervention. Proposed mechanisms 
of change included improved perceived control, hope and action, changes in personal 
mind-set, as well as opportunities within the groups for social comparison, social control, 
and peer-sharing. However, no quantitative evaluation of the efficacy of the programme 
appears to be currently available. 
Behavioural Relaxation Training (BRT) 
BRT focuses on progressive muscle relaxation techniques aimed at relieving muscular 
tension, on the hypothesis that it represents a physiological response to anxiety, and that 
therefore relaxing muscles will reduce anxious symptoms (McCallie, Blum, & Hood, 
2006). Techniques may involve progressive attention to muscle groups along with the act 
of tensing and releasing in turn while focusing on the sensation of release following 
tension, and this may be supported by relaxing music or guided narratives. Two single 
case studies reported reductions in both therapist-rated and patient-rated measures for 
social anxiety (Lundervold, Pahwa, & Lyons, 2013) and generalised anxiety (Lundervold, 
Pahwa, & Lyons, 2008) post-treatment. While both studies employed BRT techniques 
that taught 10 overt relaxed behaviours, the latter also combined imagery and coping 
techniques. Sessions were short, lasting around 15 to 20 minutes and required daily 
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practice, and both studies reported the intervention as acceptable to participants. 
Other approaches 
Along with the most commonly adopted therapeutic models, a number of single studies 
exploring other less frequent approaches were identified by the present review. These are 
briefly outlined below, in descending order of study methodological complexity.  
Acceptance and Commitment Therapy (ACT) 
ACT aims to improve individuals’ acceptance of distressing thoughts, beliefs, sensations 
and emotions, contending that this will generate behavioural change and consequently 
improved quality of life (Hayes, 2004). Emphasis is usually put on moving towards key 
goals and acting upon values which are most important to the person, designing 
behavioural changes which direct one towards living these values. One RCT explored the 
adoption of ACT to target self-efficacy and anxiety in people with PD (Ghielen et al., 
2017). The intervention consisted of a group body awareness training (BEWARE) based 
on psycho-education, training in ACT, imaginary exposure using FEEL (Feeling 
Experiences Enriches Living) exercises, diminishing avoidance behaviour, physical 
exercises, and homework assignments. The results showed a significant improvement in 
emotional well-being but no changes in self-efficacy.  
Psychodrama 
Psychodrama is a therapeutic technique based on discussions of interactions and the 
dramatisation and role-playing of situations of daily life from an individual’s past 
(Moreno, 1946). One RCT evaluated a psychodrama intervention for people with PD 
consisting of two 90-minute group sessions every fortnight (Sproesser, Viana, Quagliato, 
& de Souza, 2010). The intervention was compared to a waitlist control group, and the 
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results showed significant improvements in anxiety, depression, and quality of life at 
post-intervention. 
Behavioural Activation (BA) 
BA focuses on treating mood difficulties by trying to increase participants’ active 
involvement in therapy and life (Jacobson, Martell, & Dimidjian, 2001). Common 
techniques include scheduling activities and self-monitoring. An uncontrolled pretest-
posttest design (Butterfield et al., 2017) found that six weeks of activity scheduling and 
monitoring significantly reduced apathy and depression in 27 participants with PD, and 
these gains were maintained at 1-month follow-up. The targets for the activity scheduling 
were first agreed at a 2-hour in-person planning session, and then supported by automated 
reminders and short weekly telephone calls.  
Eye Movement Desensitization and Reprocessing (EMDR) 
EMDR focuses on reprocessing of traumatic memories, including images, emotional and 
physical responses, and changes in self-representation (Shapiro, 2017). The aim is to 
support the brain to process trauma, helping individuals develop more positive self-
representations, improve well-being, and move forwards with their lives. A single case 
study adopted EMDR to address trauma in a woman with Parkinson’s disease dementia 
(PDD; Ahmed, Mosquera, & Ross, 2018). While some improvement on subjective 
reporting of trauma symptoms and resilience were observed at post-intervention and 9-
month follow-up, no changes were found in anxiety and depression. Moreover, some 
difficulties in administering EMDR were reported, as eye movements were slowed as a 
consequence of PD. However, this study is notable for being the only one that included a 
person with PDD. While most interventions to address mood difficulties have excluded 
people with PD with any signs of cognitive impairment, this study provided preliminary 
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evidence which suggests that psychological therapies may be both required and received 
well by people with PDD.  
Discussion 
Summary of main findings  
The present review aimed at providing a comprehensive account of the breadth and 
effectiveness of psychological interventions in use for a broadly-defined set of 
psychological difficulties with people with PD. From an initial return of 4911 citations, 
56 studies were eventually considered eligible for inclusion. While these covered some 
of the most common therapeutic models alongside a few less frequent approaches, only 
21 were RCTs. Moreover, only six of these (Advocat et al., 2016; Dobkin et al., 2011; 
Dobkin et al., 2020; Kraepelien et al., 2020; Kwok et al., 2019; Son & Choi, 2018) 
enrolled samples of 30 or more participants. 
CBT was by far the most common approach, with 36 papers adopting it in some 
form. The evidence suggests that CBT can be effective to address depression and sleep 
disorders in people with PD, not only when compared to TAU, but also against other 
psychotherapy approaches (e.g., psychoeducation; Berardelli et al., 2018). However, the 
same cannot be stated for anxiety, quality of life, and impulse control disorders (ICDs), 
for which the literature presents mixed results and, in the case of ICDs, is also still 
sparse. These findings appear to be fairly consistent with what has been reported from 
previous targeted systematic reviews (Armento et al., 2012; Berardelli et al., 2015; 
Dobkin et al., 2008; Xie et al., 2015; Zečević, 2020). As only 11 out of 36 studies 
adopting CBT were RCTs (Calleo et al., 2015; Dobkin, Menza, Allen, Gara, et al., 
2011; Dobkin et al., 2020; Hadinia et al., 2016; Kraepelien et al., 2020; Lawson et al., 
2013; Leroi et al., 2010; Okai et al., 2013; Patel et al., 2017; Troeung et al., 2014; 
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Wuthrich & Rapee, 2019), further high-quality research is required to shed light on the 
impact of this approach on all these psychological outcomes.  
The second most common psychotherapeutic model was mindfulness, with 10 
studies adopting one of its many variations (e.g., MBCT, MBSR, mindfulness yoga), five 
of which were RCTs (Advocat et al., 2016; Kwok et al., 2019; Pickut et al., 2015; Rodgers 
et al., 2019; Son & Choi, 2018). However, the current evidence on mindfulness-based 
approaches for people with PD was also characterised by contrasting results, with no clear 
indication of their efficacy for anxiety, depression, or quality of life. Where positive 
results were found, a number of potential mechanisms of change were highlighted, 
including perceived control and self-confidence (e.g., Vandenberg et al., 2018). 
Therefore, further more comprehensive studies, possibly involving larger sample sizes, 
are urgently needed. 
Psychoeducation programmes were adopted by four studies, of which two were 
RCTs (Flores Alves Dos Santos et al., 2017; Guo et al., 2009). The results are mostly 
negative, with all the quantitative studies finding no significant impact on depression 
(Guo et al., 2009; Macht et al., 2007), social adjustment (Flores Alves Dos Santos et al., 
2017), and quality of life (Macht et al., 2007), and only one qualitative evaluation 
(Soundy et al., 2019) showing promising results for a peer-led psychoeducational 
intervention for newly diagnosed people with PD (‘First Steps’). However, similarly to 
mindfulness, the latter highlighted a number of potential mechanisms causing positive 
change which included perceived control and individual mindset (Soundy et al., 2019), 
thus reinforcing the case for further exploration of the concept of perceived control within 
this population.  
The current preliminary evidence on the use of BRT – based on two single case 
studies (Lundervold et al., 2008, 2013) – appears to be positive, with both investigations 
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reporting reductions in therapist- and patient-rated measures of anxiety at post-
intervention. However, this needs to be confirmed by further higher quality experimental 
investigations.  
Finally, tentative results are available from single studies exploring some forms 
of therapy which are less commonly adopted with people with PD. In particular, 
promising findings were reported for the use of ACT (Ghielen et al., 2017), psychodrama 
(Sproesser et al., 2010), and BA (Butterfield et al., 2017), while somewhat mixed results 
were observed for EMDR (Ahmed et al., 2018). For all of these, further explorations of 
their feasibility, effectiveness, and acceptability are currently needed. 
Clinical implications and future directions 
 Even though the importance of psychological approaches in people with PD has 
received more recognition compared to other neurodegenerative conditions, such as 
Huntington’s disease and motor neuron disease (Anestis, Eccles, Fletcher, French, & 
Simpson, 2020; Simpson et al., 2019; Zarotti, Dale, Eccles, & Simpson, 2020; Zarotti, 
Mayberry, Ovaska-stafford, Eccles, & Simpson, 2020), the current literature around 
psychological interventions for PD is mainly characterised by low-level and/or 
underpowered studies, and more comprehensive high-powered RCTs are urgently 
needed. In addition, since only five studies out of 56 involved samples with a mean age 
lower than 60, all of which showed promising results (Berardelli et al., 2015; Dreisig et 
al., 1999; Lundervold et al., 2013; Okai et al., 2013; Sproesser et al., 2010), further 
investigations are required to explore the impact of psychological interventions in 
younger patients, in particular due to the potentially lower severity of cognitive and 
motor difficulties.  
Based on the current evidence from this review, CBT may be recommended as 
an effective treatment for depression and sleep disorders in PD, especially with an 
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intervention duration ranging between eight and 12 weeks. However, it is currently 
more equivocal if it is effective for anxiety, quality of life, and ICDs, as well as with 
briefer forms of CBT in general (e.g., six weeks or less). A similar note of caution is 
suggested when considering mindfulness-based interventions, due to the lack of clear 
results on the effectiveness of either MBCT or MBSR. The adoption of 
psychoeducation programmes alone, on the other hand, cannot be recommended due to 
predominantly negative findings with this population. In addition, data from single 
studies appear to suggest that ACT, psychodrama, BA, and BRT may represent 
effective and feasible approaches for psychological difficulties in people with PD. 
However, no specific recommendation can be made on the evidence presently available.   
A number of suggestions for future research may also be offered from the findings 
of the present review. In particular, besides the need for more comprehensive 
investigations of the therapeutic models outlined above, a number of relevant 
psychological outcomes for people with PD are currently neglected. For instance, 
although the development of ICDs has a clear psychological component (Delaney, Leroi, 
Simpson, & Overton, 2012; Delaney, Simpson, & Leroi, 2012), only two studies have 
evaluated the effectiveness of a psychological intervention for ICDs (Jiménez-Murcia et 
al., 2012; Okai et al., 2013). Similarly, despite apathy affecting up to 40% of people with 
PD (den Brok et al., 2015), only two studies to date have explored psychological therapies 
to target it specifically, both finding promising results (Berardelli et al., 2018; Butterfield 
et al., 2017).  
In addition, even though perceived control is currently considered a critical factor 
for successful psychological adaptation to chronic illness (Dempster, Howell, & 
McCorry, 2015; Egede & Ellis, 2008) – and neurodegenerative conditions in particular 
(Eccles & Simpson, 2011; Simpson, Chatzidamianos, & Eccles, 2015; Zarotti, Coates et 
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al., 2019; Zarotti, Simpson, & Fletcher, 2019) – no intervention study has specifically 
addressed it as an outcome in people with PD. However, the results from two qualitative 
evaluations identified in this review have highlighted the potential of perceived control 
in supporting the implementation of mindfulness-based therapy (Vandenberg et al., 2018) 
and psychoeducational programmes (Soundy et al., 2019), further strengthening the case 
for more thorough explorations of this construct in this population, and its impact on 
acceptability and response to psychological treatment.  
Considering that people with PD experience a progressive loss of function, ability, 
and confidence as their condition develops, a focus on improving resilience also appears 
important. To date, however, there have been no studies of psychological therapies in PD 
with the aim of increasing resilience specifically, with only a trial of cognitive stimulation 
(Leroi et al., 2019) and a single case using EMDR (Ahmed et al., 2018) exploring it as a 
secondary outcome. Thus, there is a clear need for future research to consider how 
resilience can be best enhanced in affected individuals. 
PD can also be associated with psychotic problems, such as hallucinations across 
different sensory modalities (Goetz, Stebbins, & Ouyang, 2011). Although these can 
fluctuate over the course of the condition, they generally tend to increase over time 
(ffytche et al., 2017). Research in this area is urgently needed to interpret the importance 
of psychosocial factors in these experiences (Todd, Simpson, & Murray, 2010) and 
psychological approaches for psychosis (Louise, Fitzpatrick, Strauss, Rossell, & Thomas, 
2018) in the context of Parkinson’s. As no study has yet been carried out to evaluate any 
psychological intervention for psychosis in people with PD – and very little is also known 
regarding how affected individuals cope with these symptoms – future research in this 
area should represent a priority. 
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Finally, the intrinsic limitations of scoping reviews (e.g., lack of quantitative 
synthesis and formal qualitative assessment of evidence) should be considered when 
interpreting the abovementioned results. While this methodology was appropriate for the 
wider aim of the present study, further more focused systematic reviews and meta-
analyses are warranted in the future for each therapeutic approach in PD.  
Conclusions 
The literature available to date shows that a relatively wide range of approaches to 
psychological interventions has been adopted with people with Parkinson’s. Among 
these, CBT may be the most effective in treating depression and sleep disorders but its 
impact on anxiety, quality of life, and impulse control disorders is still unclear. For the 
same reason, evidence is still limited regarding the adoption of mindfulness-based 
interventions, while the efficacy of psychoeducation programmes alone is currently 
unproven. As we enter the new decade, more high-quality evidence is required to increase 
our understanding of psychological interventions for people with PD in general, as well 
as to confirm preliminary positive findings on the adoption of ACT, BA, BRT, and 
psychodrama. 
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Table 1. Logic grid for search strategy. 
Population Interventions  
Parkinson* disease Acceptance and commitment therapy  
Behavio* therapy  
Cognitive analytic therapy 
Cognitive behavio* therapy  
Cognitive therapy 
Compassion* focused therapy 
Counsel* 
Couple* therapy 
Dialectical behavioral therapy 
Emotion focused therapy 
Emotive behavio* therapy 










Mindfulness-based cognitive therapy 





















Table 2. Overview of adopted search terms and identified items per database. 
Search terms 
(Parkinson* disease AND Acceptance and commitment therapy) OR (Parkinson* disease AND Behavio* therapy) OR (Parkinson* disease AND Cognitive analytic 
therapy) OR (Parkinson* disease AND Cognitive behavio* therapy) OR (Parkinson* disease AND Cognitive therapy) OR (Parkinson* disease AND Compassion* focused 
therapy) OR (Parkinson* disease AND Counsel*) OR (Parkinson* disease AND Couple* therapy) OR (Parkinson* disease AND Dialectical behavioral therapy) OR 
(Parkinson* disease AND Emotion focused therapy) OR (Parkinson* disease AND Emotive behavio* therapy) OR (Parkinson* disease AND Eye movement desensiti* 
and reprocessing) OR (Parkinson* disease AND Family therapy) OR (Parkinson* disease AND Gestalt therapy) OR (Parkinson* disease AND Group* therapy) OR 
(Parkinson* disease AND Integrative therapy) OR (Parkinson* disease AND Interpersonal therapy) OR (Parkinson* disease AND Meditat*) OR (Parkinson* disease AND 
Metacognitive therapy) OR (Parkinson* disease AND Mindfulness) OR (Parkinson* disease AND Mindfulness-based cognitive therapy) OR (Parkinson* disease AND 
Mindfulness-based stress reduction) OR (Parkinson* disease AND Motivational interviewing) OR (Parkinson* disease AND Narrative therapy) OR (Parkinson* disease 
AND Person cent* therapy) OR (Parkinson* disease AND Psychoanal*) OR (Parkinson* disease AND Psychodynamic therapy) OR (Parkinson* disease AND 
Psychoeducati*) OR (Parkinson* disease AND Psychological intervention) OR (Parkinson* disease AND Psychotherap*) OR (Parkinson* disease AND Rational emotive 
behavio* therapy) OR (Parkinson* disease AND Schema therapy) OR (Parkinson* disease AND Self-management) OR (Parkinson* disease AND Solution focused 




Table 3. Key characteristics of included studies. 
Citation Category Design  Sample Intervention  Relevant outcomes Relevant measures Key results 
Ghielen et 
al., 2017 













Significant improvement in emotional 
well-being for the intervention group, but 
no changes in self-efficacy  
Butterfield 














Large effect of treatment at post-
intervention on apathy severity 
Medium to large effect on depression  
Medium effect on quality of life 
Changes in apathy and depression 
maintained at 1-month follow-up 
Lundervold 






1 BRT Anxiety BRS 
CAS 
SUD 
Systematic increases in relaxed behaviour 
and decreased ratings of distress and 
anger at post-intervention, maintained at 
follow-up  
Further decreases in distress ratings 
observed following BRT + imagery and 




et al., 2013 
BRT Single case 1 Behavioral 
Relaxation 






Systematic increases in relaxed behaviour 
and decreased ratings of distress and 
anger at post-intervention, maintained at 
follow-up  
Participant rated BRT as highly 
acceptable  
Berardelli 




7 Group CBT Anxiety 
Depression 










Significant improvements in anxiety, 
depression quality of life at post-
intervention 
Berardelli 





Group CBT Anxiety 
Apathy 
Depression 








Significant improvements in anxiety, 













High effect sizes for treatment at 1-
month follow-up for both anxiety and 
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telephone or in 
person) 





CBT Case series 5 Individual CBT 
delivered at home 
Depression 
Quality of life 
 
BDI-II 





scale for mood 
Clinically reliable reduction of depression 
in 4 participants, with greater 
improvement reported by the 2 
participants with more severe baseline 
depression    
No change in quality of life 
Dissanayak





12 Manualised and 










Significant improvements in anxiety at 
post-intervention, maintained at both 3-
month and 6-month follow-ups 
Depression improvements observed only 
at 3-month.  
Dobkin et 
al., 2006 







Meaningful reductions reported in 
depressive symptoms over the course of 
treatment, and maintained at 1-month 
follow-up  
Notable decrease in negative and suicidal 
thoughts  








15 CBT intervention 








Significant decrease in depressive 
symptoms on both clinician-rated and 
self-report measures  




CBT RCT I: 41 
C: 39 
CBT intervention 








ISI    
IQ 
MOS 
Significant improvements in depression, 












Quality of life 
Brief COPE 

















34 CBT intervention Anxiety 
Depression 
Sleep disorders 














Significant improvements in depression, 
anxiety, insomnia, and quality of life 
across all time-points  
Dobkin et 
al., 2020 






Quality of life 
BDI 





Significant improvements in anxiety, 
depression, insomnia severity, and quality 




















et al., 2010 
CBT Case series 8 CBT Depression 
Quality of life 
ADL Scale 
ATQ–R 












Significant linear decrease in mean 
depression scores over Weeks 0 to 12  








Clinically significant improvement in 
depression in three out of the four 
participants 




CBT RCT I: 16 
C: 14 
Group CBT Anxiety 
Depression 







Significantly greater improvement for the 














Sleep measures of 
interest including 
wake time after 
sleep onset, sleep 
efficiency, sleep 
onset latency, and 





Significant short-term and long-term 
reduction social anxiety in both clinician 
ratings and self-report measures 
Humbert et 
al., 2017 






Sleep disorders Sleep diaries 
Sleep measures of 
interest including 
wake time after 
sleep onset, sleep 
efficiency, sleep 
onset latency, and 
total sleep time 
Significant increases in sleep efficiency 
and decreases in number of awakenings 
per night 











CBT Impulse control GSI 
SCL-90-R 
SOGS 
No significant differences between 
groups  
Kraepelien 
et al., 2020 












Significant improvements in anxiety, 
depression, insomnia severity, and quality 
of life compared to controls 
Medium effect size for depression, but 
significantly lower compared to face to 
face studies 
Significant effects for anxiety not 
accompanied by significant improvement 
within-group, suggesting the effect could 
be partly explained by deterioration in 
the control group 
Lawson et 
al., 2013 




reading resource  
Anxiety  
Quality of life 
BBQ 
CGI – Impression – 
Severity Scale 





Significant reductions observed only for 










Significant improvements on insomnia, 






Quality of life 
  
DBAS-16 









intervention, maintained at 3-month 
follow-up  
Leroi et al., 
2010 














Sleep disorders in improved significantly 
in both intervention and psychoeducation 
groups 
No between-group differences on any 
outcome measures 
Intervention found to be well tolerated 
and feasible   
Macht et 
al., 2007 
CBT Case series 3 CBT Anxiety BELA-P-k Improvement over time for patients 
experiencing psychosocial anxiety 
Mohlman 
et al., 2010 










Participant free of generalised anxiety 







Considerable reduction in scores on all 
anxiety measures from pre- to 
posttreatment (no significance reported) 
Reductions in symptoms of depression 
(no significance reported) 
Okai et al., 
2013 
CBT RCT I: 28 
C: 17 
CBT based on a 
treatment manual 
compiled during 
the pilot phase of 










Scale (ad-hoc)  
NPI 
Frequency and impact of impulse control 
disorders significantly reduced over the 6-
month period in the treatment group 
CBT plus standard medical care appears 
to be more effective than standard 
medical care alone in reducing the 
severity of impulse control disorders in 
PwPpeople with PD 
Osawa et 
al., 2020 






Objective sleep measured by actigraph 
did not improve, subjective sleep 
measured by sleep diary improved 
No significant changes in quality of life 
Patel et al., 
2017 












Significantly greater improvements in 
insomnia scores for CBTi group 
Change was not significant at intention-
to-treat analysis likely due to the high 










9 CBT by 
videoconferencin











Significant reductions in anxiety and/or 
depression observed in seven out of nine 
participants at post-treatment 
Most improvements maintained at 6-
week follow-up 
High adherence, retention, as well as 











Reported improvements in global mental 
health and moderate reductions in 
depression 
No effect on anxiety 
Rios 
Romenets 
et al., 2013 
CBT RCT  I: 6 
C: 6 
CBTi  Depression 
Fatigue 
Quality of life 
Sleep disorders 
BDI  
CGI – Change scale  









Significant improvement in insomnia 
severity scores in the CBTi group, but no 
change in night-time sleep score 






















Significant improvements in depression at 













Quality of life 
ADL of UPDRS 
BELA-P-k 
Mood (analogue)  
PDQ-39  
SDS 
Significantly improved quality of life for 
treatment group at post-intervention  
No significant differences in depression 
Good acceptance from participants 
Troeung et 
al., 2014 
CBT RCT I: 11 
C: 7 
Group CBT  Anxiety 
Depression 





Significant improvement at post-
intervention for CBT group in anxiety and 
depression, but no differences in stress.  
Significant and large effects for 
depression, anxiety, and stress at both 1-
month and 6-month follow-ups 
No significant differences for quality of 




















Medium effect size on depression and 
medium to large on anxiety at post-
intervention and follow-up 
Small effect sizes on quality of life at all 









manualised CBT  
Anxiety 
Depression 




Significant reduction of depressive 
symptoms at post-treatment, maintained 
at 1-month follow-up 
No significant changes in anxiety and 




CBT  Uncontrolled 
pretest-
posttest 
22 CBT  Sleep disorders PDSS 
Sleep diary 
Significant improvements in total wake 
time, sleep efficiency, and overall sleep 
score at post-intervention and 3-month 
Ahmed et 
al., 2018 
EMDR Single case 1 EMDR Anxiety 
Depression  
Subjective report of 
trauma 
HADS No change in anxiety and depression 
Improvement on subjective reporting of 
trauma symptoms and resilience at post-
intervention and 9 months 
Advocat et 
al., 2016 
















No significant differences in global quality 
of life between the two groups at post-








6   Anxiety 
Depression  




Significant improvements in levels of 
depression and anxiety at both post-
intervention and follow-up 
No significant difference in quality of life 













Significant reductions in depression 
No significant changes in anxiety 
Dissanayak





















Significant reduction in anxiety, 
depression, and quality of life at post-
intervention, not maintained at follow-up 
(smaller sample due to attrition) 
Fitzpatrick 
et al., 2010 
Mindfulness Qualitative 
evaluation 
12 MBCT course  N/A N/A MBCT could benefit people with PD and 
was an acceptable form of group 
intervention. 
Kwok et al., 
2019 











Significant better outcomes for the 
mindfulness yoga group in anxiety, 
depression, and QoL at both post-
















Significant improvement for the 
intervention group in mindfulness levels. 




Mindfulness RCT I: 15 
C: 12 
Modified MBCT  Anxiety 
Depression  





Significant reduction in depressive 
symptoms for the MBCT participants at 
both group and individual levels at post-
intervention. No significant effect on 
anxiety or quality of life at the group level 
Son & Choi, 
2018 















Significant improvements for quality of 
life, anxiety and depression 
Vandenber




Advocat et al., 
2016 




N/A N/A Reported improved feelings of control, 
acceptance of disease progression, social 
relationships, and self-confidence in 
managing the disease. 
Sproesser 
et al., 2010 












Significant improvements for depression, 
anxiety, and QoL for the psychotherapy 





et al., 2017 
Psychoeducati
on 
















Significantly greater improvements in 
anxiety, depression and instrumental 
coping for the treatment group at 1 year 
No significant differences between 
groups for quality of life 














Significant improvement in quality of life 








151 Patient education 
programme  
Depression 




Significant improvements for 
psychosocial issues 
No significant improvements in 











people with PD  
N/A N/A Program found as worth-while to 
improve exercise behaviour and coping 
mechanisms  
Proposed mechanisms of impact included 
perceived control, social control, hope 
and action, and individual mindset 
Note.  AARP = Abbreviated Treatment Acceptability Rating Profile; ACQ = Anxiety Control Questionnaire; ACT = Acceptance and Commitment Therapy; ADIS-5 = Anxiety Disorders Interview 
Schedule; ADL = Activities of Daily Living; AES = Apathy evaluation scale; AES-S = Apathy Evaluation Scale–Self;  AIFQ = Adaptive Inferential Feedback Questionnaire; AS = Apathy Scale; 
ATQ-R = Automatic Thoughts Questionnaire–Revised; BA = Behavioural Activation; BAI = Beck Anxiety Inventory; BAI = Beck Anxiety Inventory; BBQ = Brunnsviken Brief Quality of life 
scale; BDI = Beck Depression Inventory; BELA-P-k = Burden Questionnaire for Patients with Parkinson’s disease; BPRS = Brief Psychiatric Rating Scale; BRS = Behavioral Relaxation Scale; 
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BRT = Behavioural Relaxation Training; C = control; CBT = Cognitive Behavioural Therapy; CAS = Clinical Anxiety Scale; CBTi = CBT for Insomnia; CCL = Cognitions Checklist; CGI = 
Clinical Global Impressions; CHIP = Coping Health Injuries and Problems; CORE-10 = Clinical Outcomes Routine Evaluation Scale, 10-item version; CSD-E = Expanded Consensus Sleep 
Diary for evening; DAS = Dysfunctional Attitude Scale; DASS = Depression, Anxiety and Stress Scale; DBAS-16 = Dysfunctional Beliefs and Attitudes about Sleep; EMDR = Eye Movement 
Desensitization and Reprocessing; EQ-5D = EuroQol-5 Dimension; ESS = Epworth Sleepiness Scale: FFMQ = Five Facet Mindfulness Questionnaire; FKK = Questionnaire for Disease-Related 
Communication; FMI = Freiburg Mindfulness Inventory; GAD-7 = Generalized Anxiety Disorder-7; GAI = Geriatric Anxiety Inventory; GDS = Geriatric Depression Scale; GHQ–28 = General 
Health Questionnaire; GSI = Global Severity Index; GRID-HAMD = GRID-Hamilton Depression Rating Scale; HADS = Hospital Anxiety and Depression Scale; HAM-A = Hamilton Anxiety 
Scale; HAM-D = Hamilton Depression Rating Scale; HWS = Holistic Well-being Scale; I = intervention; IQ = Inference Questionnaire; ISI = Insomnia Severity Index; IUS = Intolerance of 
Uncertainty Scale; IUS = Intolerance of Uncertainty Scale; LARS = Lille Apathy Rating Scale; LSAS = Liebowitz Social Anxiety Scale; MAAS = Mindful Attention Awareness Scale; MADRS 
= Montgomery-Asberg Depression Rating Scale; MBCT = Mindfulness Based Cognitive Therapy; MBSR = Mindfulness Based Stress Reduction; MCQ-30 = Metacognitions Questionnaire; 
MCS = Mental Health Composite Score; MHLC-B = Form B of the Multidimensional Health Locus of Control; MOS = Medical Outcome Study; N/A = Not Applicable; NEADL = Nottingham 
Extended Activities of Daily Living index; NPI = Neuropsychiatric inventory; OASIS= Overall Anxiety Severity and Impairment Scale; ODSIS= Overall depression severity and impairment 
scale; OQ-45 = Outcome Questionnaire; PAS = Parkinsonʼs anxiety scale; PD = Parkinson’s disease; PDQ = Parkinson's Disease Questionnaire; PDQL = Parkinson's Disease Quality of Life 
Questionnaire; PDSI = Parkinson’s disease summary index score; PDSS = Parkinson’s Disease Sleep Scale; PFS = Parkinson Fatigue Scale; PHQ-9 = Patient Health Questionnaire; PIRS20 = 
Pittsburgh Insomnia Rating Scale; PMS = Global patient’s mood status; PSAS = PreSleep Arousal Scale; PSQI = Pittsburgh Sleep Quality Index; PSS = Perceived Stress Scale; PSWQ = Penn 
State Worry Questionnaire; RCT = Randomised Controlled Trial; SAS = Social adjustment scale; SCI = Sleep Condition Indicator; SCID = Structured Clinical Interview for DSM-IV; SCL-90-
R = Symptom Checklist-90 items-Revised; SDS = Self-Rating Depression Scale; SEADL = Schwab and England Activities of Daily Living; SES = Self‐efficacy for sleep scale; SF-36 = Short 
Form Health Survey; SFQ = Social Feedback Questionnaire; SHI = Sleep Hygiene Index; SIGH-A = Structured Interview Guide for the Hamilton Anxiety Scale; SIGH-D = Structured Interview 
Guide for the Hamilton Depression Scale; SOGS = South Oaks Gambling Screen; SPAI = Social Phobia and Anxiety Inventory; SPEFI = Social Phobia Endstate Functioning Index; SQ = 
Kellner’s Symptom Questionnaire; SRBQ-20 = Sleep‐related behaviors questionnaire 20; SSPS = Self-Statements during Public Speaking Scale; STAI = State–Trait Anxiety Inventory; STAI-S 
= State Anxiety Subscale of the STAI; STAI-T = Trait Subscale of the STAI; StAS = Starkstein Apathy Scale; SUD = Subjective Unit of Discomfort; UPDRS = Unified Parkinson’s Disease 
Rating Scale; WCC = Ways of Coping Checklist; WHOQOL = World Health Organisation Quality of Life-Brief.  
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Records after limiting to peer-
reviewed English articles,  
and removal of duplicates  
(n = 2094) 
 
Records excluded 
(n = 2006) 
Full-text articles excluded 
(n = 32) 
 
Conference proceedings: 1 
Focus on cognition/neuroimaging: 2 
Insufficient details on therapy: 3 
Letter to Editor: 1 
No specific data for PwP: 3 
Not a psychological intervention: 9 
Not an intervention study: 5 
Protocol/manual only: 8 
 
Full-text articles  
assessed for eligibility 
(n = 88) 
 
Studies included in review 
(n = 56) 
Total identified records 
 (n = 4911) 
Records screened  
by title and abstract  
(n = 2094) 
 
 
PsycINFO 
1006 
CINHAL 
597 
ASU 
1168 
Cochrane 
417 
MEDLINE 
1723 
